TSX:WELLHealthcare
Did WELL Health’s Reaffirmed 2026 Guidance and Narrowing Losses Just Shift WELL Health Technologies' (TSX:WELL) Investment Narrative?
In May 2026, WELL Health Technologies Corp. reported first-quarter results showing sales of CA$368.26 million versus CA$294.14 million a year earlier, with net loss narrowing to CA$12.38 million from CA$46.57 million.
On the same day, the company reaffirmed its 2026 annual revenue guidance of CA$1.55 billion to CA$1.65 billion, underscoring management’s confidence in the current business trajectory despite remaining losses.
We’ll now examine how WELL’s reaffirmed 2026 revenue guidance...